A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)

Summary

This single site study will examine plasma and alveolar compartment (AC) levels of posaconazole in cystic fibrosis (CF) and non-cystic fibrosis (non-CF) lung transplant recipients receiving routine post-operative anti-fungal prophylaxis. Invasive fungal infection rates will be assessed following transplantation.

Timeline

Start

2013-01-23

Primary completion

2014-01-16

Completion

2014-01-16

Drugs

Indications